Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Mechanisms of Immunomodulator Sensitivity and Resistance in Multiple Myeloma

NCT05288062 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05288062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05288062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Mechanisms of Immunomodulator Sensitivity and Resistance in Multiple Myeloma
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Terminated
Start date
June 15, 2022
Completion date
July 30, 2025
Enrollment
17 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma, recurrent multiple myeloma, refractory multiple myeloma, smoldering multiple myeloma